UCB's Global Corporate Website
Welcome to UCB in the United States

Jan

18

Positive Top-Line Results for bimekizumab in Phase 3 Non-Radiographic Axial Spondyloarthritis Study

Dec

16

Positive Top-Line Results for Bimekizumab in Phase 3 Ankylosing Spondylitis Trial

Dec

10

UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis

Dec

03

Unleashing the Power of Digital Solutions in Epilepsy Care

UCB’s Head of Digital Business Transformation, Colin Lake speaks to the current landscape in digital business transformation and neurology.

Dec

03

UCB to present new data at the American Epilepsy Society 75th Annual Meeting 2021, reinforcing long-standing commitment to advancing epilepsy treatment and care

Dec

02

Working Toward a More Equitable Future: Addressing Barriers in the Hispanic Epilepsy Community

To better understand the experiences of Hispanic people with epilepsy and to improve our collective effort to break down barriers to equitable health outcomes, UCB is working with patients and their families, as well as health equity experts. Learn more.

Nov

19

Positive Top-Line Results from Bimekizumab Phase 3 Psoriatic Arthritis Study Demonstrated Significant Improvements in Joint and Skin Symptoms

Nov

11

Mission-driven, Patient-focused: How Healthcare Gave Me a Second Chance to Serve

During my time in the Navy, I developed a strong sense of purpose, service and mission. After fulfilling my service obligation, I was eager to find another career that continued to allow me to do something larger than myself. I found at UCB, a company that makes medicines to help improve the lives of people living with epilepsy, a different type of service: service to patients.

Nov

08

Epilepsy & Caregiving: A Caregiver’s Perspective on the Role of Telehealth

UCB spoke with caregiver, Debbie, about her experience caring for her daughter living with epilepsy and its personal impact on her, as well as the important role of telehealth in epilepsy care. Her story speaks to the challenges many caregivers face when looking after their loved ones and the importance of prioritizing their own mental health. As one of UCB’s Epilepsy Advocates and as a patient advocate for the Epilepsy Foundation, Debbie supports others living with epilepsy and their families throughout their healthcare journey. In these roles, she helps many find access to the right mental health resources, which she says can be a “game changer” for both epilepsy patients and their loved ones.

Nov

05

UCB Showcases Key Rheumatology Data at ACR Convergence 2021